Hyperventilation Syndrome Following an Asymptomatic COVID-19 Infection

Inês Teixeira Farinha; Alexandra Tenda Cunha; Cidália Rodrigues; Filipa Costa

doi:10.20344/amp.19995

Hyperventilation Syndrome Following an Asymptomatic COVID-19 Infection

Authors

Inês Teixeira Farinha Department of Pulmonology. Centro Hospitalar e Universitário de Coimbra. Coimbra. https://orcid.org/0000-0002-6161-8547
Alexandra Tenda Cunha Department of Pulmonology. Centro Hospitalar e Universitário de Coimbra. Coimbra.
Cidália Rodrigues Department of Pulmonology. Centro Hospitalar e Universitário de Coimbra. Coimbra.
Filipa Costa Department of Pulmonology. Centro Hospitalar e Universitário de Coimbra. Coimbra.

DOI:

https://doi.org/10.20344/amp.19995

Keywords:

COVID-19, Hyperventilation

Abstract

N/a.

Downloads

Download data is not yet available.

References

Boulding R, Stacey R, Niven R, Fowler SJ. Dysfunctional breathing: a review of the literature and proposal for classification. Eur Respir Rev. 2016;25:287-94.

Taverne J, Salvator H, Leboulch C, Barizien N, Ballester M, Imhaus E, et al. High incidence of hyperventilation syndrome after COVID-19. J Thorac Dis. 2021;13:3918-22.

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417-8.

Jack S, Rossiter HB, Pearson MG, Ward SA, Warburton CJ, Whipp BJ. Ventilatory responses to inhaled carbon dioxide, hypoxia, and exercise in idiopathic hyperventilation. Am J Respir Crit Care Med. 2004;170:118-25.

Downloads

Published

2023-10-02

How to Cite

Teixeira Farinha I, Tenda Cunha A, Rodrigues C, Costa F. Hyperventilation Syndrome Following an Asymptomatic COVID-19 Infection. Acta Med Port [Internet]. 2023 Oct. 2 [cited 2024 Nov. 22];36(10):690-1. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/19995

Download Citation

Issue

Vol. 36 No. 10 (2023): October

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.